Insys Therapeutics is an American specialty pharmaceutical company based in Chandler, Arizona. Its main product is Subsys, a sublingual liquid form of fentanyl. The drug fentanyl is a very fast acting and powerful opioid used to relieve peaks of pain in cancer patients.
Insys Therapeutics founder John Kapoor was sentenced to 66 months in prison on Thursday. Reuters reports Kapoor is being jailed for his role in an opioid fraud scheme. The billionaire is among a group..
A New York doctor was convicted on Thursday of accepting thousands of dollars in bribes and kickbacks from Insys Therapeutics Inc in exchange for prescribing his patients an addictive fentanyl spray.. Reuters - Published
A federal judge on Tuesday partially overturned the convictions of Insys Therapeutics Inc's founder and three former executives accused of bribing doctors to prescribe an addictive opioid, but declined.. Reuters - Published
Drugmaker Insys Therapeutics Inc outlined a deal on Thursday to divide its dwindling cash among governments, insurers, hospitals and individuals who accused the company of fueling the U.S. opioid.. Reuters - Published
Drugmaker Insys Therapeutics Inc on Thursday won court approval to sell its flagship fentanyl spray to a buyer who agreed to only market the drug for use by cancer patients, in response to concerns.. Reuters - Published
A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to.. Reuters - Published
Insys Therapeutics Inc said on Thursday Chairman Steven Meyer and board member Pierre Lapalme will resign, a day after the opioid drugmaker agreed to settle a kickback probe with the U.S. Department of.. Reuters - Published